Congenital ichthyosiform erythroderma due to a CYP4F22 mutation responds to ustekinumab: A case report and review of the literature

J Eur Acad Dermatol Venereol. 2023 Mar;37(3):e389-e391. doi: 10.1111/jdv.18605. Epub 2022 Oct 7.
No abstract available

Publication types

  • Review
  • Case Reports
  • Letter

MeSH terms

  • Humans
  • Ichthyosiform Erythroderma, Congenital* / drug therapy
  • Ichthyosiform Erythroderma, Congenital* / genetics
  • Mutation
  • Ustekinumab* / therapeutic use

Substances

  • Ustekinumab